Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity

被引:6
作者
Capasso, G
Unwin, R
Ciani, F
Rizzo, A
Russo, F
Pica, A
De Santo, NG
机构
[1] Univ Naples 2, Chair Nephrol, I-80131 Naples, Italy
[2] Univ Naples 2, Dept Biol Struct & Funct, I-80131 Naples, Italy
[3] UCL Royal Free & Univ Coll Med Sch, Ctr Nephrol, London, England
关键词
cyclosporin; thiorphan; atrial natriuretic peptide; glomerular filtration fate; acute renal failure; neutral endopeptidase;
D O I
10.1159/000045785
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The use of cyclosporin A (CyA) is limited by its significant nephrotoxicity. Atrial natriuretic peptide (ANP) has been shown to ameliorate the reduction in glomerular filtration rate (GFR) induced by CyA, but its effect is transient. One explanation may be the rapid breakdown of this hormone by neutral endopeptidase (NEP) which is highly active in the kidney. In the present study, we examined the effect of the NEP inhibitor thiorphan on the acute fall in GFR induced by CyA. Methods: After a first set of experiments to investigate the renal hemodynamic effects of CyA (20 mg.kg(-1), i.v. bolus), we studied four additional conditions where acute CyA treatment was followed by the administration of: (2) ANP alone (10 mug.kg(-1) i.v. as bolus and a maintenance infusion of 1 mug.kg(-1).min(-1)); (3) thiorphan alone (5 mg.kg(-1) i.v. as bolus and a maintenance infusion of 0.5 mg.kg(-1).min(-1)); (4) ANP plus thiorphan las in 2 and 3), and (5) an infusion of 0.9% saline, increased from 1.2 to 3 ml.h(-1) The GFR was measured as the clearance of H-3-methoxyinulin (ml.min(-1) 100 g(-1) body weight). Results: The data show: (I)the GFR fell from 1.06 +/- 0.15 to 0.59 +/- 0.09 ml.min(-1).100 g(-1) (p < 0.01] 60 min after CyA and remained depressed for at least 2 h; (2) ANP caused a marked initial rise in GFR from 0.49 +/- 0.07 to 1.23 +/- 0.18 ml.min(-1).100 g(-1) (p < 0.005 vs. CyA) which declined rapidly to the value seen after CyA injection alone, despite continuing ANP infusion; (3) thiorphan caused a modest, but significant increase in GFR within 15 min from 0.48 +/- 0.04 to 0.69 +/- 0.10 ml.min(-1).100 g(-1) fp < 0.05 vs. CyA) which was sustained during infusion and for at least 30 min after stopping infusion; (4) ANP plus thiorphan produced a marked increase in GFR from 0.58 +/- 0.09 to 1.39 +/- 0.44 ml.min(-1).100 g(-1) (p < 0.05 vs. CyA) which then decreased, but remained above the post-CyA injection value, until infusion of both drugs ended; (5) more than doubling the saline infusion rate per se had no significant effect on the GFR response to CyA. The blood pressure decreased significantly during ANP infusion, but more so when combined with thiorphan. Conclusion: These data indicate that the inhibition of NEP by thiorphan is able to ameliorate partially the reduction in GFR induced by CyA and to enhance, and prolong, the vasodilator and diuretic effects of ANP. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 35 条
[1]   Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].
Bennett, WM ;
DeMattos, A ;
Meyer, MM ;
Andoh, T ;
Barry, JM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100
[2]   Role of NO in cyclosporin nephrotoxicity:: effects of chronic NO inhibition and NO syntheses gene expression [J].
Bobadilla, NA ;
Gamba, G ;
Tapia, E ;
García-Torres, R ;
Bolio, A ;
López-Zetina, P ;
Herrera-Acosta, J .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (04) :F791-F798
[3]   CYCLOSPORINE-INDUCED SYNTHESIS OF ENDOTHELIN BY CULTURED HUMAN ENDOTHELIAL-CELLS [J].
BUNCHMAN, TE ;
BROOKSHIRE, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :310-314
[4]   PROTECTION OF GLOMERULAR-FILTRATION RATE BY THE THROMBOXANE RECEPTOR ANTAGONIST L655,240 DURING LOW-DOSE CYCLOSPORINE ADMINISTRATION [J].
BUNKE, M ;
WILDER, L ;
MARTIN, A .
PROSTAGLANDINS, 1992, 43 (04) :351-360
[5]   PREVENTION OF EXPERIMENTAL CYCLOSPORINE-INDUCED INTERSTITIAL FIBROSIS BY LOSARTAN AND ENALAPRIL [J].
BURDMANN, EA ;
ANDOH, TF ;
NAST, CC ;
EVAN, A ;
CONNORS, BA ;
COFFMAN, TM ;
LINDSLEY, J ;
BENNETT, WM .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 269 (04) :F491-F499
[6]   THE BENEFICIAL EFFECT OF ATRIAL-NATRIURETIC-PEPTIDE ON CYCLOSPORINE NEPHROTOXICITY [J].
CAPASSO, G ;
ROSATI, C ;
CIANI, F ;
GIORDANO, DR ;
RUSSO, F ;
DESANTO, NG .
AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (03) :204-210
[7]  
CAPASSO G, 1990, KIDNEY PROTEINS DRUG, V83, P216
[8]   PHARMACOLOGICAL PROFILE OF A NONPEPTIDIC DUAL INHIBITOR OF NEUTRAL ENDOPEPTIDASE-24.11 AND ENDOTHELIN-CONVERTING ENZYME [J].
DELOMBAERT, S ;
GHAI, RD ;
JENG, AY ;
TRAPANI, AJ ;
WEBB, RL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (01) :407-412
[9]   EFFECT OF NEUTRAL ENDOPEPTIDASE ON PLASMA AND TISSUE CONCENTRATIONS OF VASOACTIVE-INTESTINAL-PEPTIDE [J].
DUGGAN, KA ;
JONES, DM ;
DAVIS, RE ;
MACDONALD, GJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (04) :307-309
[10]   INHIBITION OF NEUTRAL ENDOPEPTIDASE STIMULATES RENAL SODIUM-EXCRETION IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
DUSSAULE, JC ;
MICHEL, C ;
PERALDI, MN ;
LECOMTE, JM ;
GROS, C ;
MIGNON, F ;
ARDAILLOU, R .
CLINICAL SCIENCE, 1993, 84 (01) :31-39